Share this article and save a life!
The rumors are true: We’ve officially entered the AI diagnostic revolution in healthcare.
The FDA has now approved over 1,250 AI-enabled medical devices, with 750+ in radiology alone. But it’s not just about quantity – the quality and capability advancements are mind-blowing.
🔍 Philips’ new SmartSpeed Precise technology is a game-changer, delivering:
• Brain scans in under 10 SECONDS (vs. traditional 30+ minutes)
• Up to 3X faster overall scan times
• 80% sharper images with enhanced detail
This isn’t incremental improvement – it’s transformative.
For patients: Less time in the claustrophobic tube, fewer motion artifacts, and dramatically reduced waiting lists. One hospital system reported cutting their MRI backlog by 61% in just three months.
For radiologists: Higher throughput without sacrificing quality – actually improving it. The AI enhancement means clearer images with fewer artifacts, enabling more confident readings in less time.
For hospital operations: The ROI is compelling. Facilities are reporting 40% more scans per day on existing machines, plus reduced overtime and staffing pressure.
For smaller facilities: This brings advanced diagnostics capabilities to community hospitals that previously couldn’t afford top-tier equipment. The AI bridges the technology gap.
💡 The bigger picture? We’re witnessing the collapse of diagnostic bottlenecks that have plagued healthcare for decades.
This isn’t just about MRIs either. Similar AI acceleration is happening across imaging modalities:
• FDA-cleared portable AI-enhanced MRI devices enable bedside imaging with real-time optimization
• RapidAI’s solution automates critical aortic measurements and 3D reconstructions
• Next-gen CT scanners use AI to reduce radiation exposure by up to 78%
For healthcare executives, this creates both opportunity and urgency. The diagnostic landscape is being rewritten, and organizations that leverage these technologies effectively will gain significant competitive advantages in quality, efficiency, and patient satisfaction.
Which AI diagnostic technologies are you evaluating? And how are you preparing your organization to fully capture their value?
Share this article and save a life!
Author:
Jonathan Govette is a seasoned healthcare and technology executive with more than two decades of experience building, scaling, and advising digital health companies. He is the Co-Founder and CEO of Oatmeal Health, an AI-driven Lung Cancer Screening and Diagnostics company focused on expanding access to early detection for underrepresented populations, particularly patients served by Federally Qualified Health Centers and value-based health plans.
With a background in engineering, product development, and strategic partnerships, Jonathan has founded and led multiple health technology ventures across clinical care delivery, regulated medical software, and AI-enabled diagnostics. His work sits at the intersection of medicine, technology, and health equity, with a consistent focus on translating complex clinical problems into scalable, real-world solutions.
Jonathan has spent much of his professional life dedicated to improving outcomes for marginalized and underserved communities. He has designed and implemented frameworks that align clinical quality, reimbursement, and technology to sustainably advance health equity at scale. This mission is deeply personal and informs his leadership philosophy and long-term vision for healthcare transformation.
In addition to his operating experience, Jonathan is an author and long-time writer in the healthcare domain, with over 20 years of published work covering digital health, medical innovation, and healthcare systems. He is a frequent mentor to early-stage founders and regularly advises startups on product strategy, partnerships, and go-to-market execution in regulated healthcare environments.
Before entering industry full-time, Jonathan nearly pursued a career in medicine with an early path toward cardiothoracic surgery, an experience that continues to shape his clinical perspective and respect for frontline care delivery.
CEO | Oatmeal Health | AI Lung Cancer Startup | Engineer | Writer | Almost Became a Doctor (Cardiac Thoracic Surgeon) | 3x Health Tech Founder | Startup Mentor | Follow to share what I’ve learned along the way.
